Labcorp Holdings Inc. [LH] stock is trading at $220.51, up 2.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LH shares have gain 1.77% over the last week, with a monthly amount drifted -1.87%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Labcorp Holdings Inc. [NYSE: LH] stock has seen the most recent analyst activity on October 01, 2024, when Piper Sandler initiated its Neutral rating and assigned the stock a price target of $235. Previously, Argus upgraded its rating to Buy on March 25, 2024, and kept the price target unchanged to $250. On February 26, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $260 on the stock. Evercore ISI started tracking the stock assigning a In-line rating and suggested a price target of $240 on February 09, 2024. Barclays initiated its recommendation with a Equal Weight and recommended $222 as its price target on January 03, 2024. HSBC Securities started tracking with a Hold rating for this stock on September 06, 2023, and assigned it a price target of $210. In a note dated December 12, 2022, Citigroup downgraded an Neutral rating on this stock and revised its target price from $275 to $250.
Labcorp Holdings Inc. [LH] stock has fluctuated between $191.97 and $238.46 over the past year. Currently, Wall Street analysts expect the stock to reach $281.25 within the next 12 months. Labcorp Holdings Inc. [NYSE: LH] shares were valued at $220.51 at the most recent close of the market. An investor can expect a potential return of 27.55% based on the average LH price forecast.
Analyzing the LH fundamentals
Labcorp Holdings Inc. [NYSE:LH] reported sales of 12.49B for the trailing twelve months, which represents a growth of 6.17%. Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 214.38 points at the first support level, and at 208.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 224.70, and for the 2nd resistance point, it is at 228.90.
Ratios To Look Out For
For context, Labcorp Holdings Inc.’s Current Ratio is 0.88. Further, the Quick Ratio stands at 0.77, while the Cash Ratio is 0.07. Considering the valuation of this stock, the price to sales ratio is 1.48, the price to book ratio is 2.31 and price to earnings (TTM) ratio is 41.88.
Transactions by insiders
Recent insider trading involved DiVincenzo Jonathan P., Officer, that happened on Sep 03 ’24 when 5460.0 shares were purchased. EVP, Chief Legal Officer, van der Vaart Sandra D completed a deal on Aug 19 ’24 to sell 2000.0 shares. Meanwhile, Officer van der Vaart Sandra D bought 2000.0 shares on Aug 19 ’24.
